Ligand Pharmaceuticals (LGND) Divestments (2026)

Ligand Pharmaceuticals (LGND) posted Divestments of $431000.0 for Q1 2026.

Ligand Pharmaceuticals (LGND) Divestments (2026) Analysis & Trends

Ligand Pharmaceuticals has reported Divestments for 1 years, with the latest figure at $431000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 9.82 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -13.21 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Ligand Pharmaceuticals 5.87 Bn 4.51 Bn 60.48 Mn 614,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 614,000.00
Mar 31, 2026 431,000.00